EPO Patent Publication: Oral Therapeutic Compounds Inhibiting HMG-CoA Reductase
Summary
The European Patent Office has published patent application EP4709402A1 for oral therapeutic compounds designed to inhibit HMG-CoA reductase enzyme activity. The application lists Difass International S.p.A. as the applicant.
What changed
This document is a publication of a European patent application (EP4709402A1) related to compositions for oral use that inhibit HMG-CoA reductase enzyme activity. The applicant is Difass International S.p.A. This publication represents the granting of a patent, which provides exclusive rights for the invention.
While this is a patent publication and not a regulatory rule imposing direct compliance obligations on companies, it is relevant for pharmaceutical and biotechnology companies operating in the EU. Companies involved in the development or commercialization of HMG-CoA reductase inhibitors should be aware of this patent to assess potential intellectual property conflicts and market exclusivity.
Source document (simplified)
COMPOSITIONS FOR ORAL USE WITH HMG-COA REDUCTASE ENZYME INHIBITING ACTIVITY
Publication EP4709402A1 Kind: A1 Mar 18, 2026
Applicants
Difass International S.p.A.
Inventors
AGOSTINI, Alida, BENVENUTI, Francesca, GIORGINI, Davide
IPC Classifications
A61K 36/63 20060101AFI20241115BHEP A61K 36/53 20060101ALI20241115BHEP A61K 36/06 20060101ALI20241115BHEP A61K 31/047 20060101ALI20241115BHEP A61K 36/82 20060101ALI20241115BHEP A61K 31/05 20060101ALI20241115BHEP A61K 31/115 20060101ALI20241115BHEP A61K 31/122 20060101ALI20241115BHEP A61K 31/355 20060101ALI20241115BHEP A61K 31/4045 20060101ALI20241115BHEP A61K 31/714 20060101ALI20241115BHEP A61K 33/06 20060101ALI20241115BHEP A61P 3/06 20060101ALI20241115BHEP A61K 9/20 20060101ALI20241115BHEP A61K 36/02 20060101ALI20241115BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Therapeutics (A61P) publishes new changes.